Space Weapons Are Official. Which Defence Contractors Get the Budget?
The Space Force’s first public admission of on-orbit weapons is less a geopolitical headline than a procurement signal, and the money trails point to specific names.
Manufacturing Slowed and Prices Rose. The Fed Decides Today.
Empire State fell 13 points to 7.6, Japan’s machinery orders dipped again, and a hike is widely expected at 2 PM ET.
Have you noticed this weird daily anomaly?
A note from our friends at Media Pub(ad) Most traders have never noticed the weird market anomaly that happens at…
SoftBank Is Funding US Data Centers With Japanese Household Money
SB Energy plans to sell up to $500 million of its IPO shares in Japan.
BofA’s Fee Miss Puts JPMorgan in the Hot Seat Today
Moynihan guided $200-$400 million below Street expectations. Doug Petno speaks at 2:45 ET and can either confirm the damage or contain it.
Tired of Overpriced Tech? Here’s a $4 Trillion Opportunity
September 15, 2026 Bonus Content: Lululemon’s Supply Chain Fix Can’t Outrun the Legging Collapse A note from our friends at…
Visa Is Rewiring Corporate Payouts. Banks Should Pay Attention.
With $25 trillion in cross-border B2B flows in its sights and stablecoin rails now live across 18 billion endpoints, Visa’s SMB payout push is a fresh competitive threat to business banking.
GTCR Is Buying SPS Commerce. The Stock Still Hasn’t Priced It In.
A credible private equity bid and 17 times earnings can help underwrite your downside.
Central Banks Are Quietly Walking Away From the Dollar
September 14, 2026 Bonus Content: Gold Keeps Falling Into a Rate Hike. Real Yields Explain Why. A note from our…
Pharma Dividends Face Their Real Test on September 29
J&J, Pfizer, and Merck head into New York with 16 days before 232 pharma tariffs expand. Here is what income investors need to know.